Optic Neuritis Treatment Market Trends

Growth Drivers

Spiking Cases of Blindness across the Globe- Optic neuritis (ON) is a disorder that affects the eye and your vision when the nerve to the eye gets inflamed. Moreover, blindness or vision loss of one eye is a symptom of optic neuritis and it can be treated with optic neuritis treatment, this drives the growth of the market. The number of people who are losing their vision is rising, and it is predicted that over the next 30 years, eyesight loss is predicted to rise by over 50% across the globe.
Growing Cases of Autoimmune Disorders- This autoimmune disorder such as multiple sclerosis causes immune system cells and antibodies to attack the optic nerves and may cause damage. Optic neuritis is a common visual symptom of multiple sclerosis; the lifetime chance of acquiring multiple sclerosis is over 45% following one episode of optic neuritis.

Challenges

Side Effects of Treatment such as Weight Gain, Increased Blood Pressure, and Others- This treatment has its benefits however it also does have some side effects which include weight gain, increased blood pressure, and others, which are especially seen in the geriatric population.
Lack of Requisite Awareness of the Treatment
Increment in the Utilization of Prednisolone Prednisone

Optic Neuritis Treatment Market: Key Insights

Base Year	2022
Forecast Year	2023-2035
CAGR	~5%
Base Year Market Size (2022)	~USD 220 million
Forecast Year Market Size (2035)	~ USD 450 million
Regional Scope	North America (U.S. & Canada) Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa)

Base Year	2024
Forecast Year	2025-2037
CAGR	5.6%
Base Year Market Size (2024)	USD 245.1 million
Forecast Year Market Size (2037)	USD 497.71 million
Regional Scope	North America (U.S., and Canada) Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific) Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Latin America (Mexico, Argentina, Brazil, Rest of Latin America) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of optic neuritis treatment is estimated at USD 267.55 million.

The optic neuritis treatment market size was over USD 245.1 million in 2024 and is anticipated to cross USD 497.71 million by 2037, witnessing more than 5.6% CAGR during the forecast period i.e., between 2025-2037. Rising incidences of bacterial infections across the globe and the significant increment in global geriatric population will boost the market growth.

North America industry is likely to hold largest revenue share of 35% by 2037, impelled by higher adoption of steroids in the region.

The major players in the market are Santen Pharmaceutical Co., Ltd., Mallinckrodt plc, AbbVie Inc., Novartis AG, Sanofi-aventis Groupe, AdvoCare International, Hikma Pharmaceuticals PLC, Henry Schein, Inc., Fresenius Kabi USA, Pfizer Inc.

Optic Neuritis Treatment Market Trends